{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:54:04Z","timestamp":1781661244277,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Glocal University Project, supported by the RISE (Regional Innovation System & Education) program funded by the Ministry of Education"},{"name":"Foundational and Protective Field of Studies Support Project at Changwon National University in 2024"},{"name":"the National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["RS-2025-16071386"],"award-info":[{"award-number":["RS-2025-16071386"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nutr"],"DOI":"10.1186\/s40795-026-01334-z","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:56:57Z","timestamp":1777355817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dietary advanced glycation end products and risk of cardiometabolic disorders in older adults: cross-sectional data from the 2007\u20132021 Korea National Health and Nutrition Examination Survey (KNHANES)"],"prefix":"10.1186","volume":"12","author":[{"given":"Arti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"1334_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12902-024-01561-0","volume":"24","author":"M Ebrahimpur","year":"2024","unstructured":"Ebrahimpur M, Mohammadi-Vajari E, Sharifi Y, Ghotbi L, Sarvari M, Ayati A, Hashemi B, Shadman Z, Khashayar P, Ostovar A, et al. Evaluation of the prevalence of cardiometabolic disorders (diabetes, hypertension, and hyperlipidemia) diagnosed, undiagnosed, treated, and treatment goal in the elderly: Bushehr Elderly Health Program (BEH). BMC Endocr Disord. 2024;24:29.","journal-title":"BMC Endocr Disord"},{"key":"1334_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41598-024-83914-2","volume":"15","author":"M Zhu","year":"2025","unstructured":"Zhu M, Jin H, Yin Y, Xu Y, Zhu Y. Association of cardiometabolic index with all-cause and cardiovascular mortality among middle-aged and elderly populations. Sci Rep. 2025;15:681.","journal-title":"Sci Rep"},{"key":"1334_CR3","doi-asserted-by":"publisher","first-page":"e069397","DOI":"10.1136\/bmjopen-2022-069397","volume":"13","author":"S Wu","year":"2023","unstructured":"Wu S, Xu W, Guan C, Lv M, Jiang S, Jinhua Z. Global burden of cardiovascular disease attributable to metabolic risk factors, 1990\u20132019: An analysis of observational data from a 2019 Global Burden of Disease study. BMJ Open. 2023;13:e069397.","journal-title":"BMJ Open"},{"key":"1334_CR4","doi-asserted-by":"publisher","first-page":"14594","DOI":"10.1038\/s41598-025-99358-1","volume":"15","author":"X Wu","year":"2025","unstructured":"Wu X, Sha J, Yin Q, Gu Y, He X. Global burden of hypertensive heart disease and attributable risk factors, 1990\u20132021: Insights from the global burden of disease study 2021. Sci Rep. 2025;15:14594.","journal-title":"Sci Rep"},{"key":"1334_CR5","doi-asserted-by":"publisher","first-page":"e0119582","DOI":"10.1371\/journal.pone.0119582","volume":"10","author":"R Wang","year":"2015","unstructured":"Wang R, Fratiglioni L, Liang Y, Welmer AK, Xu W, Mangialasche F, Johnell K, Qiu C. Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: A population-based study. PLoS ONE. 2015;10:e0119582.","journal-title":"PLoS ONE"},{"key":"1334_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3803\/EnM.2025.2398","volume":"40","author":"EJ Rhee","year":"2025","unstructured":"Rhee EJ. Prevalence and current status of cardiometabolic risk factors in Korean adults based on fact sheets 2024. Endocrinol Metab (Seoul). 2025;40:174\u201384.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1334_CR7","doi-asserted-by":"crossref","unstructured":"Clemente-Su\u00e1rez VJ, Beltr\u00e1n-Velasco AI, Redondo-Fl\u00f3rez L, Mart\u00edn-Rodr\u00edguez A, Tornero-Aguilera JF. Global impacts of Western diet and its effects on metabolism and health: A narrative review. Nutrients. 2023;15:2749.","DOI":"10.3390\/nu15122749"},{"key":"1334_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.4093\/dmj.2024.0659","volume":"48","author":"X Wang","year":"2024","unstructured":"Wang X, Sun Q. Ultra-processed foods and the impact on cardiometabolic health: The role of diet quality. Diabetes Metab J. 2024;48:1047\u201355.","journal-title":"Diabetes Metab J"},{"key":"1334_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41591-023-02260-4","volume":"29","author":"M Valles-Colomer","year":"2023","unstructured":"Valles-Colomer M, Menni C, Berry SE, Valdes AM, Spector TD, Segata N. Cardiometabolic health, diet and the gut microbiome: A meta-omics perspective. Nat Med. 2023;29:551\u201361.","journal-title":"Nat Med"},{"key":"1334_CR10","doi-asserted-by":"publisher","first-page":"111887","DOI":"10.1016\/j.isci.2025.111887","volume":"28","author":"RP Liu","year":"2025","unstructured":"Liu RP, Senior A, Bao Z, Koay YC, Holmes A, O\u2019Sullivan JF. Multi-organ multi-omic and gut microbiome markers of fat and sucrose dietary oversupply in cardiometabolic disease. iScience. 2025;28:111887.","journal-title":"iScience"},{"key":"1334_CR11","doi-asserted-by":"crossref","unstructured":"Chatzi CA, Basios A, Markozannes G, Ntzani EE, Tsilidis KK, Kazakos K, Agouridis AP, Barkas F, Pappa M, Katsiki N, Rizos EC. Effect of different dietary patterns on cardiometabolic risk factors: An umbrella review of systematic reviews and meta-analyses. Nutrients. 2024;16:3873.","DOI":"10.3390\/nu16223873"},{"key":"1334_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12944-023-01803-5","volume":"22","author":"E Birkeland","year":"2023","unstructured":"Birkeland E, Gharagozlian S, Valeur J, Aas AM. Short-chain fatty acids as a link between diet and cardiometabolic risk: A narrative review. Lipids Health Dis. 2023;22:40.","journal-title":"Lipids Health Dis"},{"key":"1334_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/0003319720916301","volume":"71","author":"EM Yubero-Serrano","year":"2020","unstructured":"Yubero-Serrano EM, P\u00e9rez-Mart\u00ednez P. Advanced glycation end products and their involvement in cardiovascular disease. Angiology. 2020;71:698\u2013700.","journal-title":"Angiology"},{"key":"1334_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11892-017-0891-2","volume":"17","author":"C Lu\u00e9vano-Contreras","year":"2017","unstructured":"Lu\u00e9vano-Contreras C, G\u00f3mez-Ojeda A, Mac\u00edas-Cervantes MH, Garay-Sevilla ME. Dietary advanced glycation end products and cardiometabolic risk. Curr Diab Rep. 2017;17:63.","journal-title":"Curr Diab Rep"},{"key":"1334_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","volume":"3","author":"A Stirban","year":"2014","unstructured":"Stirban A, Gawlowski T, Roden M. Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms. Mol Metab. 2014;3:94\u2013108.","journal-title":"Mol Metab"},{"key":"1334_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","volume":"4","author":"Z Hegab","year":"2012","unstructured":"Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4:90\u2013102.","journal-title":"World J Cardiol"},{"key":"1334_CR17","doi-asserted-by":"publisher","first-page":"e111593","DOI":"10.1371\/journal.pone.0111593","volume":"9","author":"HD Woo","year":"2014","unstructured":"Woo HD, Shin A, Kim J. Dietary patterns of Korean adults and the prevalence of metabolic syndrome: A cross-sectional study. PLoS ONE. 2014;9:e111593.","journal-title":"PLoS ONE"},{"key":"1334_CR18","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.26599\/FSHW.2022.9250159","volume":"13","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Li H, Zheng R, Cao L, Zhang S, Zhang S, Sheng H, Jiang Y, Wang Y, Fu L. Comprehensive analysis of advanced glycation end-products in commonly consumed foods: Presenting a database for dietary AGEs and associated exposure assessment. Food Sci Hum Wellness. 2024;13:1917\u201328.","journal-title":"Food Sci Hum Wellness"},{"key":"1334_CR19","doi-asserted-by":"crossref","unstructured":"Twarda-Clapa A, Olczak A, Bia\u0142kowska AM, Kozio\u0142kiewicz M. Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022;11:1312.","DOI":"10.3390\/cells11081312"},{"key":"1334_CR20","doi-asserted-by":"publisher","first-page":"e2021025","DOI":"10.4178\/epih.e2021025","volume":"43","author":"K Oh","year":"2021","unstructured":"Oh K, Kim Y, Kweon S, Kim S, Yun S, Park S, Lee YK, Kim Y, Park O, Jeong EK. Korea National Health and Nutrition Examination Survey, 20th anniversary: Accomplishments and future directions. Epidemiol Health. 2021;43:e2021025.","journal-title":"Epidemiol Health"},{"key":"1334_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.foodchem.2015.06.049","volume":"190","author":"J Scheijen","year":"2016","unstructured":"Scheijen J, Clevers E, Engelen L, Dagnelie PC, Brouns F, Stehouwer CDA, Schalkwijk CG. Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database. Food Chem. 2016;190:1145\u201350.","journal-title":"Food Chem"},{"key":"1334_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.foodchem.2011.08.055","volume":"131","author":"GLJ Hull","year":"2012","unstructured":"Hull GLJ, Woodside JV, Ames JM, Cuskelly GJ. N\u03b5-(carboxymethyl)lysine content of foods commonly consumed in a Western style diet. Food Chem. 2012;131:170\u20134.","journal-title":"Food Chem"},{"key":"1334_CR23","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.lanhl.2025.100742","volume":"6","author":"R C\u00f3rdova","year":"2025","unstructured":"C\u00f3rdova R, Kim J, Thompson AS, Noh H, Shah S, Dahm CC, Jensen CF, Mellemkj\u00e6r L, Tj\u00f8nneland A, Katzke V, et al. Plant-based dietary patterns and age-specific risk of multimorbidity of cancer and cardiometabolic diseases: a prospective analysis. Lancet Healthy Longev. 2025;6:100742.","journal-title":"Lancet Healthy Longev"},{"key":"1334_CR24","doi-asserted-by":"crossref","unstructured":"Dur\u00e3o C, Severo M, Oliveira A, Lopes C. Sex-heterogeneity on the association between dietary patterns at 4 years of age with adiposity and cardiometabolic risk factors at 10 years of age. Nutrients. 2022;14:540.","DOI":"10.3390\/nu14030540"},{"key":"1334_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1186\/s12889-024-18468-z","volume":"24","author":"M Norouzzadeh","year":"2024","unstructured":"Norouzzadeh M, Teymoori F, Farhadnejad H, Moslehi N, Mirmiran P, Rahideh ST, Azizi F. Cigarette smoking and cardiovascular disease incidence and all-cause mortality: the modifying role of diet quality. BMC Public Health. 2024;24:1021.","journal-title":"BMC Public Health"},{"key":"1334_CR26","doi-asserted-by":"publisher","first-page":"e010437","DOI":"10.1136\/bmjopen-2015-010437","volume":"6","author":"D Sluik","year":"2016","unstructured":"Sluik D, Brouwer-Brolsma EM, de Vries JH, Geelen A, Feskens EJ. Associations of alcoholic beverage preference with cardiometabolic and lifestyle factors: the NQplus study. BMJ Open. 2016;6:e010437.","journal-title":"BMJ Open"},{"key":"1334_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.2012.156","volume":"307","author":"U Ekelund","year":"2012","unstructured":"Ekelund U, Luan J, Sherar LB, Esliger DW, Griew P, Cooper A. Moderate to vigorous physical activity and sedentary time and cardiometabolic risk factors in children and adolescents. JAMA. 2012;307:704\u201312.","journal-title":"JAMA"},{"key":"1334_CR28","first-page":"100252","volume":"15","author":"X Xiao","year":"2021","unstructured":"Xiao X, Qin Z, Lv X, Dai Y, Ciren Z, Yangla Y, Zeng P, Ma Y, Li X, Wang L, et al. Dietary patterns and cardiometabolic risks in diverse less-developed ethnic minority regions: results from the China Multi-Ethnic Cohort (CMEC) Study. Lancet Reg Health West Pac. 2021;15:100252.","journal-title":"Lancet Reg Health West Pac"},{"key":"1334_CR29","doi-asserted-by":"publisher","first-page":"e2451837","DOI":"10.1001\/jamanetworkopen.2024.51837","volume":"7","author":"P Wang","year":"2024","unstructured":"Wang P, Gao X, Willett WC, Giovannucci EL. Socioeconomic status, diet, and behavioral factors and cardiometabolic diseases and mortality. JAMA Netw Open. 2024;7:e2451837.","journal-title":"JAMA Netw Open"},{"key":"1334_CR30","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/ajcn\/65.4.1220S","volume":"65","author":"WC Willett","year":"1997","unstructured":"Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220. S-8S; discussion 9S-31S.","journal-title":"Am J Clin Nutr"},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"101734","DOI":"10.1016\/j.molmet.2023.101734","volume":"73","author":"FAC Jansen","year":"2023","unstructured":"Jansen FAC, Fogliano V, Rubert J, Hoppenbrouwers T. Dietary Advanced Glycation End products interacting with the intestinal epithelium: What do we really know? Mol Metab. 2023;73:101734.","journal-title":"Mol Metab"},{"key":"1334_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3945\/an.115.008433","volume":"6","author":"J Uribarri","year":"2015","unstructured":"Uribarri J, del Castillo MD, de la Maza MP, Filip R, Gugliucci A, Luevano-Contreras C, Mac\u00edas-Cervantes MH, Markowicz Bastos DH, Medrano A, Menini T, et al. Dietary advanced glycation end products and their role in health and disease. Adv Nutr. 2015;6:461\u201373.","journal-title":"Adv Nutr"},{"key":"1334_CR33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3945\/ajcn.2009.28737","volume":"91","author":"I Birlouez-Aragon","year":"2010","unstructured":"Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, Ait-Ameur L, Lacoste F, Niamba CN, Alt N, Somoza V, Lecerf JM. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr. 2010;91:1220\u20136.","journal-title":"Am J Clin Nutr"},{"key":"1334_CR34","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1017\/S000711451800079X","volume":"119","author":"I Drake","year":"2018","unstructured":"Drake I, Sonestedt E, Ericson U, Wallstr\u00f6m P, Orho-Melander M. A Western dietary pattern is prospectively associated with cardio-metabolic traits and incidence of the metabolic syndrome. Br J Nutr. 2018;119:1168\u201376.","journal-title":"Br J Nutr"},{"key":"1334_CR35","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/s41598-017-02268-0","volume":"7","author":"E Baye","year":"2017","unstructured":"Baye E, Kiriakova V, Uribarri J, Moran LJ, de Courten B. Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: Meta-analysis of randomised controlled trials. Sci Rep. 2017;7:2266.","journal-title":"Sci Rep"},{"key":"1334_CR36","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/advances\/nmab072","volume":"12","author":"E Sharifi-Zahabi","year":"2021","unstructured":"Sharifi-Zahabi E, Sharafabad FH, Abdollahzad H, Malekahmadi M, Rad NB. Circulating Advanced Glycation End Products and their soluble receptors in relation to all-cause and cardiovascular nortality: A systematic review and meta-analysis of prospective observational studies. Adv Nutr. 2021;12:2157\u201371.","journal-title":"Adv Nutr"},{"key":"1334_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12937-021-00730-4","volume":"20","author":"C Qin","year":"2021","unstructured":"Qin C, Lv J, Yu C, Guo Y, Bian Z, Gao M, Du H, Yang L, Chen Y, Shen L, et al. Dietary patterns and cardiometabolic diseases in 0.5 million Chinese adults: a 10-year cohort study. Nutr J. 2021;20:74.","journal-title":"Nutr J"},{"key":"1334_CR38","doi-asserted-by":"crossref","unstructured":"Kim Y. Blood and tissue Advanced Glycation End Products as determinants of cardiometabolic disorders focusing on human studies. Nutrients. 2023;15:2002.","DOI":"10.3390\/nu15082002"},{"key":"1334_CR39","doi-asserted-by":"publisher","first-page":"e1900934","DOI":"10.1002\/mnfr.201900934","volume":"65","author":"D Sergi","year":"2021","unstructured":"Sergi D, Boulestin H, Campbell FM, Williams LM. The role of dietary Advanced Glycation End Products in metabolic dysfunction. Mol Nutr Food Res. 2021;65:e1900934.","journal-title":"Mol Nutr Food Res"},{"key":"1334_CR40","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","volume":"271","author":"M-X Fu","year":"1996","unstructured":"Fu M-X, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The Advanced Glycation End Product, N\u220a-(Carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem. 1996;271:9982\u20136.","journal-title":"J Biol Chem"},{"key":"1334_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-2007-985370","volume":"116","author":"S Schmitt","year":"2008","unstructured":"Schmitt S, Linder M, St\u00e4ndker L, Hammes HP, Preissner KT. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis. Exp Clin Endocrinol Diabetes. 2008;116:26\u201334.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1334_CR42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/ajkd.2001.27695","volume":"38","author":"Z Wagner","year":"2001","unstructured":"Wagner Z, Wittmann I, Maz\u00e1k I, Schinzel R, Heidland A, Kientsch-Engel R, Nagy J. N\u03f5-(carboxymethyl)lysine levels in patients with type 2 diabetes: Role of renal function. Am J Kidney Dis. 2001;38:785\u201391.","journal-title":"Am J Kidney Dis"},{"key":"1334_CR43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12872-022-02694-7","volume":"22","author":"LY Li","year":"2022","unstructured":"Li LY, Chen S, Li FF, Wu ZM, Shen Y, Ding FH, Wang XQ, Shen WF, Chen QJ, Dai Y, Lu L. High serum levels of N-epsilon-carboxymethyllysine are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery. BMC Cardiovasc Disord. 2022;22:282.","journal-title":"BMC Cardiovasc Disord"},{"key":"1334_CR44","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1152\/physrev.00001.2019","volume":"100","author":"CG Schalkwijk","year":"2020","unstructured":"Schalkwijk CG, Stehouwer CDA. Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases. Physiol Rev. 2020;100:407\u201361.","journal-title":"Physiol Rev"},{"key":"1334_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/meta.2003.50035","volume":"52","author":"BK Kilhovd","year":"2003","unstructured":"Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF. Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism. 2003;52:163\u20137.","journal-title":"Metabolism"},{"key":"1334_CR46","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s10157-016-1301-9","volume":"21","author":"K Ito","year":"2017","unstructured":"Ito K, Sakata N, Nagai R, Shirakawa JI, Watanabe M, Mimata A, Abe Y, Yasuno T, Sasatomi Y, Miyake K, et al. High serum level of methylglyoxal-derived AGE, N\u03b4-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine, independently relates to renal dysfunction. Clin Exp Nephrol. 2017;21:398\u2013406.","journal-title":"Clin Exp Nephrol"},{"key":"1334_CR47","doi-asserted-by":"publisher","first-page":"b26","DOI":"10.1016\/0002-9149(93)90142-Y","volume":"71","author":"TJ Lyons","year":"1993","unstructured":"Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol. 1993;71:b26\u201331.","journal-title":"Am J Cardiol"},{"key":"1334_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/1574884711666160511150028","volume":"11","author":"TA Ajith","year":"2016","unstructured":"Ajith TA, Vinodkumar P. Advanced Glycation End Products: Association with the pathogenesis of diseases and the current therapeutic advances. Curr Clin Pharmacol. 2016;11:118\u201327.","journal-title":"Curr Clin Pharmacol"},{"key":"1334_CR49","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.2337\/db15-0575","volume":"64","author":"G Daffu","year":"2015","unstructured":"Daffu G, Shen X, Senatus L, Thiagarajan D, Abedini A, Hurtado Del Pozo C, Rosario R, Song F, Friedman RA, Ramasamy R, Schmidt AM. RAGE suppresses ABCG1-mediated macrophage cholesterol efflux in diabetes. Diabetes. 2015;64:4046\u201360.","journal-title":"Diabetes"},{"key":"1334_CR50","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4239\/wjd.v14.i3.222","volume":"14","author":"ZQ Wang","year":"2023","unstructured":"Wang ZQ, Yao HP, Sun Z. N(\u03b5)-(carboxymethyl)lysine promotes lipid uptake of macrophage via cluster of differentiation 36 and receptor for advanced glycation end products. World J Diabetes. 2023;14:222\u201333.","journal-title":"World J Diabetes"},{"key":"1334_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1515\/JBCPP.2002.13.3.201","volume":"13","author":"M Dworacka","year":"2002","unstructured":"Dworacka M, Winiarska H, Szyma\u0144ska M, Szczawi\u0144ska K, Wierusz-Wysocka B. Serum N-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patients. J Basic Clin Physiol Pharmacol. 2002;13:201\u201313.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"1334_CR52","doi-asserted-by":"crossref","unstructured":"Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int Suppl. 2007;106:S17\u201326.","DOI":"10.1038\/sj.ki.5002382"},{"key":"1334_CR53","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/gtc.12036","volume":"18","author":"D Han","year":"2013","unstructured":"Han D, Yamamoto Y, Munesue S, Motoyoshi S, Saito H, Win MT, Watanabe T, Tsuneyama K, Yamamoto H. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic \u03b2-cell failure in type 2 diabetes. Genes Cells. 2013;18:302\u201314.","journal-title":"Genes Cells"},{"key":"1334_CR54","doi-asserted-by":"crossref","unstructured":"Gutowska K, Czajkowski K, Kury\u0142owicz A. Receptor for the Advanced Glycation End Products (RAGE) pathway in adipose tissue metabolism. Int J Mol Sci. 2023;24:10982.","DOI":"10.3390\/ijms241310982"},{"key":"1334_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/08916930902831746","volume":"42","author":"HL Nienhuis","year":"2009","unstructured":"Nienhuis HL, Westra J, Smit AJ, Limburg PC, Kallenberg CG, Bijl M. AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis. Autoimmunity. 2009;42:302\u20134.","journal-title":"Autoimmunity"},{"key":"1334_CR56","doi-asserted-by":"publisher","first-page":"107282","DOI":"10.1016\/j.phrs.2024.107282","volume":"206","author":"M Zhou","year":"2024","unstructured":"Zhou M, Zhang Y, Shi L, Li L, Zhang D, Gong Z, Wu Q. Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions - A review. Pharmacol Res. 2024;206:107282.","journal-title":"Pharmacol Res"},{"key":"1334_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9:53.","journal-title":"Signal Transduct Target Ther"},{"key":"1334_CR58","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3390\/microorganisms10091848","volume":"10","author":"VP Reddy","year":"2022","unstructured":"Reddy VP, Aryal P, Darkwah EK. Advanced Glycation End Products in health and disease. Microorganisms. 2022;10:1848.","journal-title":"Microorganisms"},{"key":"1334_CR59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s10020-023-00715-5","volume":"29","author":"M Shu","year":"2023","unstructured":"Shu M, Cheng W, Jia X, Bai X, Zhao Y, Lu Y, Zhu L, Zhu Y, Wang L, Shu Y, et al. AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE\/NF-\u03baB\/Caveolin-1 pathway. Mol Med. 2023;29:113.","journal-title":"Mol Med"},{"key":"1334_CR60","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-0035-1570754","volume":"25","author":"E McNair","year":"2016","unstructured":"McNair E, Qureshi M, Prasad K, Pearce C. Atherosclerosis and the hypercholesterolemic AGE-RAGE axis. Int J Angiol. 2016;25:110\u20136.","journal-title":"Int J Angiol"},{"key":"1334_CR61","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.phrs.2009.01.006","volume":"60","author":"S Yamagishi","year":"2009","unstructured":"Yamagishi S, Nakamura K, Matsui T. Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease. Pharmacol Res. 2009;60:174\u20138.","journal-title":"Pharmacol Res"},{"key":"1334_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40980-020-00061-8","volume":"8","author":"KW Kim","year":"2020","unstructured":"Kim KW, Kim OS. Super aging in South Korea unstoppable but mitigatable: A sub-national scale population projection for best policy planning. Spat Demogr. 2020;8:155\u201373.","journal-title":"Spat Demogr"}],"container-title":["BMC Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40795-026-01334-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-026-01334-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-026-01334-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:02:24Z","timestamp":1781658144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40795-026-01334-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1186\/s40795-026-01334-z","relation":{},"ISSN":["2055-0928"],"issn-type":[{"value":"2055-0928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures adhered to ethical standards and were approved by the Institutional Review Board (IRB) of the Korea Disease Control and Prevention Agency (IRB No. 2018-01-03\u20135\u00a0C-A). Additional approval for the present study was granted by the IRB of Changwon National University (IRB No. 7001066-202503-HR-012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}